Recent Security Class Actions

Inovio Pharmaceuticals Inc. Common Stock (NASDAQ: INO)

25 Days left to seek lead plaintiff status.

Company Name:Inovio Pharmaceuticals Inc. Common Stock
Stock Symbol:NASDAQ: INO
Class Period Start:10/10/2023
Class Period End (inclusive):12/26/2025
Filing Deadline:04/07/2026

The Complaint alleges that throughout the Class Period, Defendants made materially false and misleading statements regarding the Company’s business, operations, and prospects. Specifically, Defendants made false and/or misleading statements and/or failed to disclose that: (i) manufacturing for Inovio’s CELLECTRA device was deficient; (ii) accordingly, Inovio was unlikely to submit the INO-3107 BLA to the FDA by the second half of 2024; (iii) Inovio had insufficient information to justify the INO-3107 BLA’s eligibility for FDA accelerated approval or priority review; (iv) accordingly, INO-3107’s overall regulatory and commercial prospects were overstated; and (v) as a result, Defendants’ public statements were materially false and misleading at all relevant times.

Inovio Pharmaceuticals Inc. Common Stock (NASDAQ: INO) Claim Form

This field is for validation purposes and should be left unchanged.
Name(Required)
Address